Nanoparticle-enhanced radiotherapy synergizes with PD-L1 blockade to limit post-surgical cancer recurrence and metastasis

Nature·May 20

This story is reported by Nature. Read what other outlets are saying below, then open the original report for full details.

Full coverage

1

Mapping TAM–tumor crosstalk in glioma via ligand–receptor multi-omics: mechanisms of immune evasion

Frontiers·Nov 20

2

Engineered BCG selectively triggers trained immunity in tumor-associated macrophages and sensitizes glioblastoma to radiotherapy in mice

Nature·Apr 20

3

Immunogenic Extracellular Vesicles Derived from Endoplasmic Reticulum-Stressed Tumor Cells: Implications as the Therapeutic Cancer Vaccine

ACS Publications·Dec 18

4

Bioinspired ruthenium-manganese-oxygen complex for biocatalytic and radiosensitization therapies to eradicate primary and metastatic tumors

Nature·Aug 16

5

Nanotechnology-driven strategies in postoperative cancer treatment: innovations in drug delivery systems

Frontiers·Apr 29

6

Nanoparticles that modulate immune cells - an important strategy for the future treatment of tumors

Frontiers·Apr 22

7

Cold and hot tumors: from molecular mechanisms to targeted therapy

Nature·Oct 18

8

Nanomaterials: A powerful tool for tumor immunotherapy

Frontiers·Feb 22